

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * regulation of vitamin D biosynthetic process (GO:0060556) | 6.54729636 |
| 2 | response to peptidoglycan (GO:0032494) | 6.33657128 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.79306931 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.79306931 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.79306931 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.79306931 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.79306931 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.79306931 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.39457982 |
| 10 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.05912277 |
| 11 | * regulation of vitamin metabolic process (GO:0030656) | 5.04777188 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.02828201 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.96560324 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.84733356 |
| 15 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.81929716 |
| 16 | respiratory burst (GO:0045730) | 4.74827555 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.56464204 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 4.52605378 |
| 19 | reactive oxygen species biosynthetic process (GO:1903409) | 4.47233310 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.32141314 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.31075044 |
| 22 | superoxide anion generation (GO:0042554) | 4.30290676 |
| 23 | granulocyte activation (GO:0036230) | 4.29937686 |
| 24 | response to muramyl dipeptide (GO:0032495) | 4.19779451 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.13421349 |
| 26 | * positive regulation of chemokine biosynthetic process (GO:0045080) | 4.12477933 |
| 27 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.07294662 |
| 28 | positive regulation of mast cell degranulation (GO:0043306) | 4.07294662 |
| 29 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.96063685 |
| 30 | cellular response to nicotine (GO:0071316) | 3.93518083 |
| 31 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.90903309 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.85591785 |
| 33 | response to host immune response (GO:0052572) | 3.85591785 |
| 34 | germinal center formation (GO:0002467) | 3.84654791 |
| 35 | * regulation of chemokine biosynthetic process (GO:0045073) | 3.84497323 |
| 36 | neutrophil activation (GO:0042119) | 3.81070990 |
| 37 | T-helper 1 type immune response (GO:0042088) | 3.78294345 |
| 38 | * regulation of heat generation (GO:0031650) | 3.77764366 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.73786021 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.67824018 |
| 41 | * cellular response to lipopolysaccharide (GO:0071222) | 3.63481655 |
| 42 | negative regulation of interleukin-17 production (GO:0032700) | 3.62846371 |
| 43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.62468906 |
| 44 | regulation of activation of Janus kinase activity (GO:0010533) | 3.62379197 |
| 45 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.62032348 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.61069955 |
| 47 | regulation of podosome assembly (GO:0071801) | 3.60813064 |
| 48 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.59303914 |
| 49 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.58072438 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.57653543 |
| 51 | defense response to protozoan (GO:0042832) | 3.56967209 |
| 52 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.56894962 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.56484076 |
| 54 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.53999314 |
| 55 | * cellular response to molecule of bacterial origin (GO:0071219) | 3.51352068 |
| 56 | microglial cell activation (GO:0001774) | 3.49804264 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.49456295 |
| 58 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.47394986 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.47021211 |
| 60 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.45329309 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.44976072 |
| 62 | response to host (GO:0075136) | 3.44976072 |
| 63 | response to host defenses (GO:0052200) | 3.44976072 |
| 64 | * regulation of NF-kappaB import into nucleus (GO:0042345) | 3.44932030 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 3.44578053 |
| 66 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 3.43381605 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.42804721 |
| 68 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.41992080 |
| 69 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.39693531 |
| 70 | natural killer cell mediated immunity (GO:0002228) | 3.39693531 |
| 71 | regulation of chronic inflammatory response (GO:0002676) | 3.39423327 |
| 72 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.34947762 |
| 73 | * positive regulation of heat generation (GO:0031652) | 3.34570619 |
| 74 | macrophage activation (GO:0042116) | 3.34397159 |
| 75 | * positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.34395709 |
| 76 | * positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.32704912 |
| 77 | cytokine secretion (GO:0050663) | 3.31864999 |
| 78 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.31657364 |
| 79 | positive regulation of type 2 immune response (GO:0002830) | 3.30863959 |
| 80 | positive regulation of interferon-beta production (GO:0032728) | 3.29869459 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29758160 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29730087 |
| 83 | * positive regulation of acute inflammatory response (GO:0002675) | 3.29165006 |
| 84 | regulation of mononuclear cell migration (GO:0071675) | 3.28493186 |
| 85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.27050695 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.25680166 |
| 87 | eosinophil chemotaxis (GO:0048245) | 3.25539060 |
| 88 | regulation of interleukin-17 production (GO:0032660) | 3.24789478 |
| 89 | positive regulation of interleukin-12 production (GO:0032735) | 3.24621260 |
| 90 | neutrophil mediated immunity (GO:0002446) | 3.24605630 |
| 91 | * regulation of fever generation (GO:0031620) | 3.24308600 |
| 92 | * regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.23477846 |
| 93 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.22926088 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.22473414 |
| 95 | cellular response to type I interferon (GO:0071357) | 3.22473414 |
| 96 | * positive regulation of interleukin-6 production (GO:0032755) | 3.22197480 |
| 97 | leukocyte mediated cytotoxicity (GO:0001909) | 3.20958208 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 3.19727231 |
| 99 | regulation of interleukin-12 production (GO:0032655) | 3.19157421 |
| 100 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.18848654 |
| 101 | response to type I interferon (GO:0034340) | 3.18428730 |
| 102 | monocyte chemotaxis (GO:0002548) | 3.18319409 |
| 103 | lymphocyte chemotaxis (GO:0048247) | 3.17574359 |
| 104 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16959734 |
| 105 | negative regulation of lipid storage (GO:0010888) | 3.16120303 |
| 106 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.15172324 |
| 107 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.14470281 |
| 108 | positive regulation of leukocyte degranulation (GO:0043302) | 3.13901736 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.13866217 |
| 110 | negative regulation of viral genome replication (GO:0045071) | 3.13625229 |
| 111 | cellular response to interferon-beta (GO:0035458) | 3.13219672 |
| 112 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.12701222 |
| 113 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.12602979 |
| 114 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.12281565 |
| 115 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11376168 |
| 116 | B cell mediated immunity (GO:0019724) | 3.10013813 |
| 117 | * positive regulation of chemokine production (GO:0032722) | 3.09826509 |
| 118 | response to protozoan (GO:0001562) | 3.09752121 |
| 119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.08591947 |
| 120 | regulation of T-helper cell differentiation (GO:0045622) | 3.08398711 |
| 121 | cellular extravasation (GO:0045123) | 3.07310488 |
| 122 | regulation of immunoglobulin secretion (GO:0051023) | 3.05398001 |
| 123 | * cellular response to biotic stimulus (GO:0071216) | 3.04543949 |
| 124 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01463883 |
| 125 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.01407864 |
| 126 | regulation of growth of symbiont in host (GO:0044126) | 3.01407864 |
| 127 | negative regulation of growth of symbiont in host (GO:0044130) | 3.01407864 |
| 128 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.01407864 |
| 129 | regulation of mast cell activation (GO:0033003) | 3.01062637 |
| 130 | * positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.00749507 |
| 131 | negative regulation of amino acid transport (GO:0051956) | 3.00255395 |
| 132 | activation of MAPKKK activity (GO:0000185) | 3.00079081 |
| 133 | * regulation of vascular endothelial growth factor production (GO:0010574) | 2.99469836 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.98004887 |
| 135 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.94862837 |
| 136 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.92778124 |
| 137 | * positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.90291891 |
| 138 | * positive regulation of transcription factor import into nucleus (GO:0042993) | 2.86366450 |
| 139 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.86303698 |
| 140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.85928852 |
| 141 | response to manganese ion (GO:0010042) | 2.82343141 |
| 142 | * regulation of interleukin-6 production (GO:0032675) | 2.82295682 |
| 143 | positive regulation of interleukin-10 production (GO:0032733) | 2.82265751 |
| 144 | regulation of type 2 immune response (GO:0002828) | 2.80998768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.92320368 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.31187830 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.93864839 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.45724099 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.10884359 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.02946657 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99452340 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.91511301 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.78735658 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72783340 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13692396 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97741613 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91947988 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90896840 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.78935917 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67300091 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46806267 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46513022 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08953108 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06031360 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.04052378 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.01132048 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98185008 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89991330 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.83889699 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80219818 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79064900 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78669735 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75111920 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72271910 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68865668 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64591905 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62275896 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58895261 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54907366 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52537307 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47710150 |
| 38 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47356079 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43791284 |
| 40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41143391 |
| 41 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.40174457 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.40174457 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.40174457 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37812257 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36500252 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35689013 |
| 47 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30868884 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29537759 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28773030 |
| 50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25650217 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24675734 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23376961 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22760181 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20820841 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20820841 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20671741 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20402180 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19242863 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17255544 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14703315 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.11473529 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10609238 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10559352 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09547428 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09294459 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07174866 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06887577 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04883907 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04357545 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04332537 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04125539 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01843802 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.01624024 |
| 74 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01222415 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00400831 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95909249 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92761313 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 0.90573335 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88927165 |
| 80 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88266377 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87233952 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87233585 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84580627 |
| 84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83931419 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82963857 |
| 86 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81489183 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81269715 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80996788 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80630261 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80366778 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79616021 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79330778 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79006606 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78636071 |
| 95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77432627 |
| 96 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.76578660 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76322952 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.75791978 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75635297 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.74782199 |
| 101 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73334408 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.72740615 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72073708 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71646724 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71646724 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 0.70261912 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69580148 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69215229 |
| 109 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.67283020 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.66026657 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65682832 |
| 112 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.64643854 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64326831 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.61895613 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.59177514 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 0.57916493 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.57633702 |
| 118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56659772 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.55132929 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.54885909 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.53943121 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.49572107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0009785_altered_susceptibility_to | 4.55079903 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.31664361 |
| 3 | MP0003436_decreased_susceptibility_to | 4.05642867 |
| 4 | MP0003724_increased_susceptibility_to | 3.96166057 |
| 5 | MP0003303_peritoneal_inflammation | 3.93054622 |
| 6 | MP0006082_CNS_inflammation | 3.73678199 |
| 7 | * MP0002148_abnormal_hypersensitivity_rea | 3.72970260 |
| 8 | * MP0002419_abnormal_innate_immunity | 3.50719928 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.39859209 |
| 10 | * MP0005025_abnormal_response_to | 3.22758584 |
| 11 | MP0004510_myositis | 2.74790913 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.63697829 |
| 13 | MP0005387_immune_system_phenotype | 2.62189710 |
| 14 | MP0001790_abnormal_immune_system | 2.62189710 |
| 15 | * MP0002723_abnormal_immune_serum | 2.54445805 |
| 16 | MP0001800_abnormal_humoral_immune | 2.38113151 |
| 17 | MP0005671_abnormal_response_to | 2.37638186 |
| 18 | MP0004947_skin_inflammation | 2.37421344 |
| 19 | MP0000685_abnormal_immune_system | 2.30083186 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.23011653 |
| 21 | * MP0009764_decreased_sensitivity_to | 2.21026211 |
| 22 | MP0003075_altered_response_to | 2.19220938 |
| 23 | * MP0001819_abnormal_immune_cell | 2.18335398 |
| 24 | MP0009278_abnormal_bone_marrow | 2.15955095 |
| 25 | MP0001853_heart_inflammation | 2.14148293 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.14130959 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.05917818 |
| 28 | MP0005058_abnormal_lysosome_morphology | 2.00896788 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.99286410 |
| 30 | * MP0001845_abnormal_inflammatory_respons | 1.99212156 |
| 31 | MP0002405_respiratory_system_inflammati | 1.88413144 |
| 32 | * MP0008469_abnormal_protein_level | 1.85174397 |
| 33 | MP0000343_altered_response_to | 1.83965795 |
| 34 | * MP0003448_altered_tumor_morphology | 1.72487750 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.69339987 |
| 36 | MP0003195_calcinosis | 1.65684146 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.63834165 |
| 38 | MP0006054_spinal_hemorrhage | 1.54465510 |
| 39 | MP0005164_abnormal_response_to | 1.52237087 |
| 40 | MP0003186_abnormal_redox_activity | 1.49564799 |
| 41 | * MP0002006_tumorigenesis | 1.46209495 |
| 42 | * MP0000858_altered_metastatic_potential | 1.43402540 |
| 43 | MP0003828_pulmonary_edema | 1.42846187 |
| 44 | MP0000716_abnormal_immune_system | 1.42497578 |
| 45 | * MP0002998_abnormal_bone_remodeling | 1.38908533 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.34874893 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.34874893 |
| 48 | MP0003690_abnormal_glial_cell | 1.34118048 |
| 49 | * MP0005166_decreased_susceptibility_to | 1.31762355 |
| 50 | MP0000604_amyloidosis | 1.31660861 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.30778665 |
| 52 | MP0003646_muscle_fatigue | 1.29297485 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.28726910 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.28608589 |
| 55 | MP0005310_abnormal_salivary_gland | 1.27061618 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.27009392 |
| 57 | MP0004858_abnormal_nervous_system | 1.23771845 |
| 58 | MP0002398_abnormal_bone_marrow | 1.23595138 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.20831582 |
| 60 | MP0009763_increased_sensitivity_to | 1.13171680 |
| 61 | MP0002429_abnormal_blood_cell | 1.08227373 |
| 62 | MP0005390_skeleton_phenotype | 1.06259808 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.05728093 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.05275842 |
| 65 | MP0002254_reproductive_system_inflammat | 1.04376946 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.03228615 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.97151459 |
| 68 | MP0000689_abnormal_spleen_morphology | 0.96891526 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 0.94373568 |
| 70 | MP0001663_abnormal_digestive_system | 0.92548228 |
| 71 | MP0002722_abnormal_immune_system | 0.92119368 |
| 72 | MP0008260_abnormal_autophagy | 0.91575594 |
| 73 | MP0003300_gastrointestinal_ulcer | 0.91075380 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.90486483 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.88204117 |
| 76 | MP0002933_joint_inflammation | 0.87374667 |
| 77 | MP0009840_abnormal_foam_cell | 0.86597129 |
| 78 | MP0005023_abnormal_wound_healing | 0.84526845 |
| 79 | MP0008004_abnormal_stomach_pH | 0.81513681 |
| 80 | MP0001851_eye_inflammation | 0.79961640 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.79862213 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.78297335 |
| 83 | MP0008874_decreased_physiological_sensi | 0.75747222 |
| 84 | MP0001542_abnormal_bone_strength | 0.74904273 |
| 85 | MP0004883_abnormal_blood_vessel | 0.72814752 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.72474300 |
| 87 | MP0003045_fibrosis | 0.71477612 |
| 88 | MP0005647_abnormal_sex_gland | 0.70655424 |
| 89 | MP0000371_diluted_coat_color | 0.68852039 |
| 90 | MP0003795_abnormal_bone_structure | 0.68499171 |
| 91 | MP0003091_abnormal_cell_migration | 0.66879972 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.66062190 |
| 93 | * MP0000249_abnormal_blood_vessel | 0.65215175 |
| 94 | * MP0005167_abnormal_blood-brain_barrier | 0.64314477 |
| 95 | * MP0005535_abnormal_body_temperature | 0.63618576 |
| 96 | MP0005266_abnormal_metabolism | 0.63584873 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.63022249 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.62764183 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.62523073 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.60829802 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.60166138 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.59763377 |
| 103 | MP0002166_altered_tumor_susceptibility | 0.59439493 |
| 104 | MP0008873_increased_physiological_sensi | 0.58930798 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.58720986 |
| 106 | MP0000750_abnormal_muscle_regeneration | 0.58595451 |
| 107 | * MP0000920_abnormal_myelination | 0.58330767 |
| 108 | MP0005451_abnormal_body_composition | 0.57892763 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.57274335 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.55879418 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.55105440 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.55000824 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.49367384 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.49188613 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.48341347 |
| 116 | MP0001958_emphysema | 0.48189875 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48158402 |
| 118 | MP0005165_increased_susceptibility_to | 0.45990821 |
| 119 | MP0002168_other_aberrant_phenotype | 0.45785005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.03135359 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.01524770 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.48866543 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.03478861 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 6.61390018 |
| 6 | Stomatitis (HP:0010280) | 5.64431925 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.39437910 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.39287742 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.95036779 |
| 10 | Gingivitis (HP:0000230) | 4.70874896 |
| 11 | Orchitis (HP:0100796) | 4.61523419 |
| 12 | Optic neuritis (HP:0100653) | 4.47296103 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.47296103 |
| 14 | Recurrent skin infections (HP:0001581) | 4.38399135 |
| 15 | Myositis (HP:0100614) | 4.22939290 |
| 16 | Vasculitis (HP:0002633) | 4.02465313 |
| 17 | Obstructive lung disease (HP:0006536) | 3.97979988 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.97979988 |
| 19 | Loss of speech (HP:0002371) | 3.94881369 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.87122094 |
| 21 | Increased IgM level (HP:0003496) | 3.75574182 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.75297287 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 3.55583175 |
| 24 | Tetraparesis (HP:0002273) | 3.46959327 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.45621740 |
| 26 | Thick nail (HP:0001805) | 3.45243368 |
| 27 | Prostate neoplasm (HP:0100787) | 3.43828209 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.42874571 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.31422865 |
| 30 | Mutism (HP:0002300) | 3.26961774 |
| 31 | Cellulitis (HP:0100658) | 3.25621096 |
| 32 | Recurrent viral infections (HP:0004429) | 3.25606019 |
| 33 | Urticaria (HP:0001025) | 3.22388187 |
| 34 | Neurofibrillary tangles (HP:0002185) | 3.22109013 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.19408098 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.19195695 |
| 37 | Axonal loss (HP:0003447) | 3.16771796 |
| 38 | Episodic fever (HP:0001954) | 3.11707923 |
| 39 | Periodontitis (HP:0000704) | 3.09646079 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.06331489 |
| 41 | Nuclear cataract (HP:0100018) | 3.04940902 |
| 42 | Pustule (HP:0200039) | 3.02004413 |
| 43 | Esophageal neoplasm (HP:0100751) | 2.99397677 |
| 44 | Neoplasm of head and neck (HP:0012288) | 2.99397677 |
| 45 | Parakeratosis (HP:0001036) | 2.92371704 |
| 46 | Premature loss of primary teeth (HP:0006323) | 2.91854483 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.86552209 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79051027 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79051027 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79051027 |
| 51 | Recurrent pneumonia (HP:0006532) | 2.76154441 |
| 52 | Polyneuropathy (HP:0001271) | 2.75524689 |
| 53 | Apathy (HP:0000741) | 2.65435668 |
| 54 | Meningitis (HP:0001287) | 2.64370445 |
| 55 | Glomerulonephritis (HP:0000099) | 2.63099465 |
| 56 | Leukocytosis (HP:0001974) | 2.62455279 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.61787768 |
| 58 | Disinhibition (HP:0000734) | 2.61576722 |
| 59 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60752324 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60752324 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.60376038 |
| 62 | Diminished motivation (HP:0000745) | 2.58052322 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56965008 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.56965008 |
| 65 | Arterial thrombosis (HP:0004420) | 2.51239725 |
| 66 | Osteomyelitis (HP:0002754) | 2.49965793 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48607500 |
| 68 | Hemoptysis (HP:0002105) | 2.47732844 |
| 69 | Recurrent lower respiratory tract infections (HP:0002783) | 2.43463826 |
| 70 | Peritonitis (HP:0002586) | 2.43237694 |
| 71 | Myocardial infarction (HP:0001658) | 2.40958396 |
| 72 | Poor head control (HP:0002421) | 2.39602641 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.36732757 |
| 74 | Keratoconjunctivitis (HP:0001096) | 2.36711631 |
| 75 | Nausea (HP:0002018) | 2.35139139 |
| 76 | Petechiae (HP:0000967) | 2.33996518 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32069792 |
| 78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32069792 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32069792 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.30654864 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.30097364 |
| 82 | Encephalitis (HP:0002383) | 2.27878055 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 2.27649183 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.27324933 |
| 85 | Gingival bleeding (HP:0000225) | 2.26895075 |
| 86 | Porencephaly (HP:0002132) | 2.26212717 |
| 87 | Metaphyseal irregularity (HP:0003025) | 2.25255041 |
| 88 | Bone pain (HP:0002653) | 2.24973943 |
| 89 | Joint swelling (HP:0001386) | 2.24825918 |
| 90 | Vertigo (HP:0002321) | 2.24558292 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.19179592 |
| 92 | Nephritis (HP:0000123) | 2.17208650 |
| 93 | Increased IgE level (HP:0003212) | 2.15509920 |
| 94 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14798148 |
| 95 | Abnormality of the pleura (HP:0002103) | 2.14192533 |
| 96 | T lymphocytopenia (HP:0005403) | 2.13008651 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.11458677 |
| 98 | Anorexia (HP:0002039) | 2.11456268 |
| 99 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10655509 |
| 100 | Osteolytic defects of the hand bones (HP:0009699) | 2.10655509 |
| 101 | Arthralgia (HP:0002829) | 2.10400441 |
| 102 | Inappropriate behavior (HP:0000719) | 2.09528732 |
| 103 | Hematochezia (HP:0002573) | 2.09231766 |
| 104 | Amyloidosis (HP:0011034) | 2.08215431 |
| 105 | Purpura (HP:0000979) | 2.05501155 |
| 106 | Malnutrition (HP:0004395) | 2.01460919 |
| 107 | Gangrene (HP:0100758) | 1.98657584 |
| 108 | Agnosia (HP:0010524) | 1.98273432 |
| 109 | Acne (HP:0001061) | 1.96329494 |
| 110 | Restrictive lung disease (HP:0002091) | 1.96311469 |
| 111 | Pulmonary embolism (HP:0002204) | 1.95706535 |
| 112 | Memory impairment (HP:0002354) | 1.95499533 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 1.93496540 |
| 114 | Thin bony cortex (HP:0002753) | 1.93469128 |
| 115 | Chronic otitis media (HP:0000389) | 1.92899512 |
| 116 | Glomerulopathy (HP:0100820) | 1.91996339 |
| 117 | Keratitis (HP:0000491) | 1.91333770 |
| 118 | Progressive visual loss (HP:0000529) | 1.90542457 |
| 119 | Sepsis (HP:0100806) | 1.90244765 |
| 120 | Skin ulcer (HP:0200042) | 1.88775689 |
| 121 | Vertebral compression fractures (HP:0002953) | 1.88578313 |
| 122 | Joint hemorrhage (HP:0005261) | 1.88388729 |
| 123 | Abnormality of the endocardium (HP:0004306) | 1.87608694 |
| 124 | Abnormality of the prostate (HP:0008775) | 1.85475670 |
| 125 | Amaurosis fugax (HP:0100576) | 1.84399252 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84353169 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 1.82249807 |
| 128 | Dysostosis multiplex (HP:0000943) | 1.78213895 |
| 129 | Increased serum ferritin (HP:0003281) | 1.78091148 |
| 130 | Eosinophilia (HP:0001880) | 1.75202327 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.72558438 |
| 132 | Abnormality of T cell number (HP:0011839) | 1.68612694 |
| 133 | Lower limb hyperreflexia (HP:0002395) | 1.66731194 |
| 134 | Pathologic fracture (HP:0002756) | 1.66701513 |
| 135 | Cheilitis (HP:0100825) | 1.66627673 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 1.66208491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.57198584 |
| 2 | RIPK4 | 5.51222834 |
| 3 | PBK | 4.09599711 |
| 4 | TBK1 | 3.84826701 |
| 5 | BLK | 3.79354348 |
| 6 | IRAK3 | 3.56969557 |
| 7 | DDR2 | 3.29888115 |
| 8 | TXK | 2.89506262 |
| 9 | IRAK4 | 2.87614748 |
| 10 | TAOK2 | 2.74600096 |
| 11 | IKBKE | 2.70031685 |
| 12 | IKBKB | 2.58719927 |
| 13 | TYK2 | 2.42304495 |
| 14 | JAK3 | 2.33335474 |
| 15 | MAP4K1 | 2.12551712 |
| 16 | TAOK1 | 1.93130934 |
| 17 | CHUK | 1.92109609 |
| 18 | PRPF4B | 1.85379987 |
| 19 | CSK | 1.84537784 |
| 20 | PIM2 | 1.78442642 |
| 21 | ERN1 | 1.70439112 |
| 22 | MAP3K13 | 1.65968229 |
| 23 | FGR | 1.61554450 |
| 24 | JAK1 | 1.58218052 |
| 25 | CDC42BPA | 1.46723870 |
| 26 | EPHB1 | 1.45305733 |
| 27 | BMPR2 | 1.35280207 |
| 28 | MST4 | 1.35196161 |
| 29 | BMX | 1.32380892 |
| 30 | RIPK1 | 1.31716240 |
| 31 | TYRO3 | 1.31612456 |
| 32 | ZAP70 | 1.27252364 |
| 33 | LATS2 | 1.26978066 |
| 34 | ARAF | 1.24329109 |
| 35 | KIT | 1.22793303 |
| 36 | MST1R | 1.22670720 |
| 37 | ABL2 | 1.17314908 |
| 38 | HCK | 1.17015764 |
| 39 | ERBB4 | 1.16539234 |
| 40 | SYK | 1.16066838 |
| 41 | LYN | 1.14448415 |
| 42 | JAK2 | 1.13270638 |
| 43 | EIF2AK2 | 1.10166909 |
| 44 | MATK | 1.08480828 |
| 45 | EPHA3 | 1.03198112 |
| 46 | STK24 | 1.02212513 |
| 47 | MARK3 | 0.99930303 |
| 48 | PIM1 | 0.96541589 |
| 49 | IRAK1 | 0.95373452 |
| 50 | RPS6KA4 | 0.95298185 |
| 51 | YES1 | 0.93714842 |
| 52 | LCK | 0.88964974 |
| 53 | PDGFRA | 0.86707342 |
| 54 | FGFR3 | 0.83084717 |
| 55 | CSF1R | 0.81881243 |
| 56 | MAP3K5 | 0.77963050 |
| 57 | PRKCD | 0.76273368 |
| 58 | CLK1 | 0.74228819 |
| 59 | BTK | 0.73259100 |
| 60 | FGFR4 | 0.70871515 |
| 61 | ACVR1B | 0.70866961 |
| 62 | IRAK2 | 0.69945692 |
| 63 | FES | 0.65451274 |
| 64 | KSR2 | 0.63967926 |
| 65 | EGFR | 0.63716688 |
| 66 | NME2 | 0.63425416 |
| 67 | STK4 | 0.62982535 |
| 68 | ABL1 | 0.61698129 |
| 69 | SIK3 | 0.55478121 |
| 70 | STK10 | 0.55212112 |
| 71 | MAP3K1 | 0.53406967 |
| 72 | GRK7 | 0.51158708 |
| 73 | TEC | 0.49701885 |
| 74 | NEK9 | 0.46700971 |
| 75 | DYRK3 | 0.44498488 |
| 76 | PRKCQ | 0.44054858 |
| 77 | STK3 | 0.42788006 |
| 78 | FYN | 0.42352608 |
| 79 | ERBB3 | 0.42130920 |
| 80 | MAPK4 | 0.42026037 |
| 81 | PDPK1 | 0.41704663 |
| 82 | LRRK2 | 0.40835173 |
| 83 | MAP3K11 | 0.38621499 |
| 84 | CDK6 | 0.38174851 |
| 85 | PIK3CG | 0.37890028 |
| 86 | MAP3K10 | 0.37193897 |
| 87 | TAOK3 | 0.36630474 |
| 88 | MAP3K9 | 0.36563958 |
| 89 | MOS | 0.34404609 |
| 90 | PDK1 | 0.34389011 |
| 91 | PRKG2 | 0.32875781 |
| 92 | MAPKAPK2 | 0.32268358 |
| 93 | ALK | 0.31643392 |
| 94 | RPS6KL1 | 0.31086608 |
| 95 | RPS6KC1 | 0.31086608 |
| 96 | MAP2K6 | 0.30617871 |
| 97 | TTN | 0.29657346 |
| 98 | MAP2K3 | 0.28931715 |
| 99 | HIPK2 | 0.28219422 |
| 100 | BMPR1B | 0.27407273 |
| 101 | DAPK3 | 0.27107480 |
| 102 | ADRBK2 | 0.26915942 |
| 103 | TRPM7 | 0.24923610 |
| 104 | RAF1 | 0.23747243 |
| 105 | PDGFRB | 0.23653909 |
| 106 | INSR | 0.23347221 |
| 107 | RPS6KA1 | 0.23088818 |
| 108 | MAPK7 | 0.22615869 |
| 109 | NLK | 0.22389990 |
| 110 | IGF1R | 0.22261198 |
| 111 | MAP3K3 | 0.22054971 |
| 112 | TESK1 | 0.21856652 |
| 113 | TGFBR2 | 0.19994162 |
| 114 | PAK4 | 0.19736804 |
| 115 | CAMK1D | 0.19283469 |
| 116 | GSK3A | 0.19142144 |
| 117 | TESK2 | 0.19105049 |
| 118 | PTK6 | 0.18250610 |
| 119 | ICK | 0.17671604 |
| 120 | DAPK2 | 0.16940016 |
| 121 | SIK1 | 0.16245360 |
| 122 | ADRBK1 | 0.15914269 |
| 123 | MAP3K12 | 0.15611594 |
| 124 | RPS6KA5 | 0.14892539 |
| 125 | PKN1 | 0.14024034 |
| 126 | PRKAA2 | 0.13942050 |
| 127 | RPS6KA6 | 0.13823961 |
| 128 | SIK2 | 0.12783858 |
| 129 | CAMKK2 | 0.12025943 |
| 130 | KSR1 | 0.11544980 |
| 131 | CDK15 | 0.10748115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 3.94573493 |
| 2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.72786252 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.17771893 |
| 4 | * Legionellosis_Homo sapiens_hsa05134 | 3.13405149 |
| 5 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.98395660 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.90443502 |
| 7 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.81413243 |
| 8 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.73339057 |
| 9 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.57849208 |
| 10 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.57497384 |
| 11 | * Pertussis_Homo sapiens_hsa05133 | 2.52722610 |
| 12 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.50770786 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.40621401 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 2.38330121 |
| 15 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35074052 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.28206815 |
| 17 | * Malaria_Homo sapiens_hsa05144 | 2.28090251 |
| 18 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27725175 |
| 19 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.14652558 |
| 20 | * Salmonella infection_Homo sapiens_hsa05132 | 2.10866558 |
| 21 | * Measles_Homo sapiens_hsa05162 | 2.05165495 |
| 22 | * African trypanosomiasis_Homo sapiens_hsa05143 | 1.83983714 |
| 23 | * Influenza A_Homo sapiens_hsa05164 | 1.80490738 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.72795839 |
| 25 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54134574 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52174421 |
| 27 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47575456 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46468670 |
| 29 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45897571 |
| 30 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.41281713 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37413484 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.33534011 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32075055 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.26864698 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.23323059 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.20288837 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19041710 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18487688 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14930003 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04447705 |
| 41 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04008678 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.02849128 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02298321 |
| 44 | * Amoebiasis_Homo sapiens_hsa05146 | 1.00234998 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.99468472 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89116867 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88818500 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84028488 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83397673 |
| 50 | * Prion diseases_Homo sapiens_hsa05020 | 0.83026604 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79461654 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75349990 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73645582 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72199322 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70374729 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.67760979 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65907020 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60857365 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60225639 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58598164 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53365239 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52722705 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50206252 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49452617 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48795513 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48539337 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48090032 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47093586 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46530616 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44886158 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41592737 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.40280204 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39521499 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39410739 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38912696 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38416738 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34458379 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.33408068 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33002953 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31620929 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31540428 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31208673 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30339987 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23112382 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19884020 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19470019 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18733050 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18538214 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18212971 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17650923 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17626925 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17355896 |
| 93 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16283692 |
| 94 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15177315 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15123034 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.14845079 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14677366 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14235217 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.12971515 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12390520 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.12067330 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.12043044 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.08838551 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07027668 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05438790 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.04460355 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.02474768 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0124397 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0074766 |

